IndiaFilingsIndiaFilings
India FlagRegister India Company
UAE FlagRegister UAE Company
USA FlagRegister USA Company

BLUE PARADIGM PHARMACEUTICALS LLP

LLPIN : AAX-0199|ROC: RoC-MumbaiActive
Last Updated On : 10-03-2022
LLPINAAX-0199
LLP NameBLUE PARADIGM PHARMACEUTICALS LLP
Number of Partners2
Number of Designated Partners2
ROC CodeRoC-Mumbai
Date of Incorporation14-05-2021
Registered AddressOFFICE NO 1302, BUILDING NO A1, SECTOR 1, MBP, MAHAPE NAVI MUMBAI Thane MH 400710 IN
Email IDkedarvidwans@gmail.com
Total Obligation of Contribution1,00,000
Main division of business activity to be carried out in India52
Description of main divisionRetail trade,except of motor vehicles and motorcycles,repair of personal&household goods
LLP StatusActive

Directors / Signatory Details

DIN / PANNameBegin Date
07547670AVINASH SHIV SINGH NEGI14-05-2021
03554442KEDAR AVINASH VIDWANS14-05-2021
BLUE PARADIGM PHARMACEUTICALS LLP is a Limited Liability Partnership (LLP) governed by the LLP Act, 2008. Registered under the Registrar of Companies RoC-Mumbai, it operates as a non-government entity. According to the Ministry of Corporate Affairs (MCA), this LLP was incorporated on 14-05-2021 and last updated on 10-03-2022. Its LLP Identification Number (LLPIN) is , and the registration number is . Currently, its eFiling status is listed as “Active” as per MCA records.
From a financial standpoint, BLUE PARADIGM PHARMACEUTICALS LLP has a total contribution of INR 1,00,000. Details of the latest financial filings, such as the Statement of Accounts and Solvency or Annual Returns, are unavailable, indicating limited publicly disclosed financial data.
The registered office address is OFFICE NO 1302, BUILDING NO A1, SECTOR 1, MBP, MAHAPE NAVI MUMBAI Thane MH 400710 IN. Correspondence or inquiries may be sent to the official email address, kedarvidwans@gmail.com.
For those interested in further details, below are some frequently asked questions:
Disclaimer

IndiaFilings is not affiliated with any companies listed on this website and does not represent them. Please contact the respective company directly for their inquiries.